These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6125567)

  • 1. H-Pro-[3H]Leu-Gly-NH2: uptake and metabolism in rat brain.
    de Wildt D; Verhoef J; Witter A
    J Neurochem; 1982 Jan; 38(1):67-74. PubMed ID: 6125567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-Pro-[3H]Leu-Gly-NH2: plasma profile and brain uptake following subcutaneous injection in the rat.
    Verhoef J; Prins A; Veldhuis HD; Witter A
    J Neurochem; 1982 Apr; 38(4):1135-8. PubMed ID: 6121002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-Pro-[3H]Leu-Gly-NH2: metabolism in human and rat plasma investigated by high-pressure liquid chromatography.
    Witter A; Scholtens H; Verhoef J
    Neuroendocrinology; 1980 Jun; 30(6):377-81. PubMed ID: 6104307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate.
    Kastin AJ; Hahn K; Zadina JE; Banks WA; Hackler L
    J Neurochem; 1995 Apr; 64(4):1855-9. PubMed ID: 7891114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): influence on dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP).
    Torre E; Celis ME; Chiocchio SR
    Peptides; 1984; 5(4):669-74. PubMed ID: 6149522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
    Manberg PJ; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
    Kastin AJ; Hahn K; Banks WA; Zadina JE
    Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
    Vivas A; Celis ME
    Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
    Johnson RL; Rajakumar G; Yu KL; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma.
    Kastin AJ; Hahn K; Erchegyi J; Zadina JE; Hackler L; Palmgren M; Banks WA
    Biochem Pharmacol; 1994 Feb; 47(4):699-709. PubMed ID: 7907473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of analogues of Pro-Leu-Gly-NH2 modified at the leucyl residue.
    Johnson RL; Bontems RJ; Yang KE; Mishra RK
    J Med Chem; 1990 Jun; 33(6):1828-32. PubMed ID: 1971310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position.
    Johnson RL; Rajakumar G; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2100-4. PubMed ID: 2876103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of metabolism in the action of prolyl-leucyl-glycinamide on the development of tolerance to the analgesic effect of morphine.
    Bhargava HN
    Neuropharmacology; 1986 Jul; 25(7):737-41. PubMed ID: 2875417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilization in rat limbic-forebrain nuclei.
    van Heuven-Nolsen D; de Kloet ER; Versteeg DH
    Brain Res; 1984 Nov; 322(2):213-8. PubMed ID: 6150749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Des-Tyr1-gamma-endorphin (DT gamma E) and des-enkephalin-gamma-endorphin (DE gamma E): plasma profile and brain uptake after systemic administration in the rat.
    Verhoef JC; Scholtens H; Vergeer EG; Witter A
    Peptides; 1985; 6(3):467-74. PubMed ID: 4070016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of melanotropin inhibiting factor by brain.
    Hui KS; Cheng KP; Wong KH; Salschutz M; Lajtha A
    J Neurochem; 1980 Aug; 35(2):471-8. PubMed ID: 6108995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stability of prolin-containing peptides in biological media].
    Shevchenko KV; Nagaev IY; Andreeva LA; Shevchenko VP; Myasoedov NF
    Biomed Khim; 2019 Apr; 65(3):180-201. PubMed ID: 31258142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.